Citigroup’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-235,270
| Closed | -$4.22M | – | 7826 |
|
|
2017
Q4 | $4.22M | Sell |
235,270
-46,392
| -16% | -$571K | ﹤0.01% | 1992 |
|
|
2017
Q3 | $3.32M | Sell |
281,662
-57,607
| -17% | -$646K | ﹤0.01% | 2127 |
|
|
2017
Q2 | $3.56M | Buy |
339,269
+307,929
| +983% | +$3.14M | ﹤0.01% | 2013 |
|
|
2017
Q1 | $345K | Sell |
31,340
-348
| -1% | -$4.04K | ﹤0.01% | 4180 |
|
|
2016
Q4 | $429K | Buy |
31,688
+14,014
| +79% | +$196K | ﹤0.01% | 4532 |
|
|
2016
Q3 | $217K | Buy |
17,674
+6,092
| +53% | +$71.8K | ﹤0.01% | 4587 |
|
|
2016
Q2 | $127K | Sell |
11,582
-17,632
| -60% | -$197K | ﹤0.01% | 4887 |
|
|
2016
Q1 | $319K | Buy |
29,214
+6,270
| +27% | +$79.2K | ﹤0.01% | 4628 |
|
|
2015
Q4 | $396K | Buy |
22,944
+12,375
| +117% | +$222K | ﹤0.01% | 4099 |
|
|
2015
Q3 | $209K | Sell |
10,569
-6,976
| -40% | -$160K | ﹤0.01% | 4454 |
|
|
2015
Q2 | $288K | Buy |
17,545
+1,693
| +11% | +$29.4K | ﹤0.01% | 4158 |
|
|
2015
Q1 | $247K | Sell |
15,852
-5,295
| -25% | -$82.1K | ﹤0.01% | 4332 |
|
|
2014
Q4 | $302K | Buy |
21,147
+11,771
| +126% | +$124K | ﹤0.01% | 4350 |
|
|
2014
Q3 | $61K | Buy |
9,376
+467
| +5% | +$3.1K | ﹤0.01% | 5158 |
|
|
2014
Q2 | $61K | Sell |
8,909
-5,138
| -37% | -$36.3K | ﹤0.01% | 5029 |
|
|
2014
Q1 | $100K | Sell |
14,047
-2,152
| -13% | -$18.4K | ﹤0.01% | 4988 |
|
|
2013
Q4 | $152K | Sell |
16,199
-652
| -4% | -$4.65K | ﹤0.01% | 4904 |
|
|
2013
Q3 | $105K | Buy |
16,851
+8,074
| +92% | +$50.4K | ﹤0.01% | 4681 |
|
|
2013
Q2 | $58K | Buy |
+8,777
| New | +$69.6K | ﹤0.01% | 5282 |
|
Other funds holding SCMP
Citigroup's SCMP Position: Q1 2018 in Review
Citigroup sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 235,270 shares — an estimated $4.22M sold.
Citigroup first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $4.22M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Citigroup reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Citigroup sold 235,270 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $4.22M.
- Citigroup first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- Citigroup's Sucampo Pharmaceuticals, Inc. position peaked at $4.22M in Q4 2017.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Citigroup's 13F filing for Q1 2018, filed 11 May 2018.